Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HRþ/HER2þ Breast Cancer
Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew J. Brenner, Alison Stopeck, Hannah Parris, Dexiang Gao, Tessa McSpadden, Jose Mayordomo, Jennifer R. Diamond, Peter Kabos*, Virginia F. Borges*
Dive into the research topics of 'Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HRþ/HER2þ Breast Cancer'. Together they form a unique fingerprint.